This page shows the latest buprenorphine news and features for those working in and with pharma, biotech and healthcare.
and buprenorphine – saying that there wasn’t enough evidence to show it was clinically effective.
a naloxone nasal spray formulation and a sublingual spray formulation of buprenorphine in development. ... The buprenorphine spray product was however rejected by the FDA last year.
Suboxone, which is based on the powerful opioid drug buprenorphine, is approved for use by recovering opioid addicts to avoid or reduce withdrawal symptoms while they undergo treatment.
Camurus gained EU approval for its weekly and monthly Buvidal (prolonged release buprenorphine) for the treatment of opioid dependence in November, the first approval of a long-acting treatment for opioid
Other drugs gaining recommendation included:. Molteni Farmaceutici’s Sixmo (buprenorphine) an opioid dependence implant treatment that releases low levels of buprenorphine into the patient’s body for six months.
He says some medicines would be “particularly vulnerable" - highlighting a current shortage of pain and opioid addiction treatment Buprenorphine and antipsychotic Risperidone, arising in particular because there are no simple alternatives
More from news
Approximately 1 fully matching, plus 22 partially matching documents found.
Indivior discovered buprenorphine, sold it under the brand name Subutex to treat opioid addiction in 1996 and has since expanded its portfolio with Suboxone tablets, Suboxone Film, the monthly injectable Sublocade ... of buprenorphine that addresses the
CAM2038 is an injectable solution that slowly releases buprenorphine – the most common drug used to treat opioid addiction – into the body, eliminating the need for daily dosages as well as the
deal? Coincidentally, the third late stage deal this month is also an analgesic, a buprenorphine implant lasting for six months for maintenance treatment of opioid dependence; the NDA was submitted in ... 335. Titan / Braeburn. Commercialisation and
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...